Accordingly, there has been support for the notion that both the higher RCC incidence seen with type 2B and type 1 VHL mutations and the lack of pheochromocytoma in type 1 mutants may be a result of higher HIF-α levels [33,34]. The gene discussed is VHL; the disease is hereditary pheochromocytoma-paraganglioma.